Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals. - Wikidata - wikimedia - TriplyDB

Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals.

Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals.

http://www.wikidata.org/entity/Q33991362

about

HIV infection and older Americans: the public health perspective Cardiovascular Complications of HIV in Endemic Countries.Initiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease?HIV infection, inflammation, immunosenescence, and aging.T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHS VS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics.Immunologic basis of cardiovascular disease in HIV-infected adults.The effect of a "universal antiretroviral therapy" recommendation on HIV RNA levels among HIV-infected patients entering care with a CD4 count greater than 500/μL in a public health setting Immune dysregulation and vascular risk in HIV-infected patients: implications for clinical care.T cell activation predicts carotid artery stiffness among HIV-infected women Assessment of arterial elasticity among HIV-positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women.A randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection.Markers of endothelial dysfunction, coagulation and tissue fibrosis independently predict venous thromboembolism in HIV.Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda.Plasmacytoid dendritic cells in HIV infection.High retention in care among HIV-infected patients entering care with CD4 levels >350 cells/μL under routine program conditions in Uganda.Progression of carotid intima-media thickness and coronary artery calcium over 6 years in an HIV-infected cohort.Is arterial stiffness in HIV-infected individuals associated with HIV-related factors?The association of CD4+ T-cell counts and cardiovascular risk in treated HIV disease Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy.Dendritic cell dysregulation during HIV-1 infection.Innate immune evasion strategies by human immunodeficiency virus type 1.Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population.Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy.Brachial and central blood pressure in HIV-infected subjects.Renal impairment is associated with coronary heart disease in HIV-positive men.Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study.Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms.Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America.

P2860

Q26858824-0FED60FD-2E7C-4DFD-8695-49FF45DB84ED Q30244655-2D31C505-CFDB-4649-8A7D-D915E37ED5A3 Q33649200-EA0F8660-2616-4BB8-B763-2F86295A0C0C Q34150710-A31D8181-3679-4F0D-8163-3608E3C6DA43 Q34342183-8E747F27-DAAE-42F3-A816-EFD4D8FF6825 Q34456352-1F641494-FA44-4DC1-8A9B-9C84314A2347 Q34638205-DA034343-6E62-4DBD-AAD0-280563C56877 Q34642257-F71F211F-BD39-4A09-A455-EBD0D59992CD Q34764372-3862CEA6-6AD9-4EEB-AF0A-2ED8BD282039 Q35113323-6F61E75B-5A00-42DB-AF67-127427A1031E Q35124958-D55B7AD5-39A9-4060-AC7B-E737B147637B Q36154044-65030455-45E7-42F1-BDAF-C3E8D361024B Q36346646-582A3704-1ADC-4B9A-802E-09AF60B4299D Q36377944-3C2770A5-D2FB-4ECB-B203-DDAB43976228 Q36379299-F9A5C588-F4B9-417F-BF19-94EE1E998B58 Q36522679-7776307C-E2DC-4382-9EAB-1F5F6C1FDD34 Q37019332-0EE805AD-879E-45A8-8439-06DD5BD34496 Q37220792-BB1BD01C-6208-4B0A-8CB3-CB0076AD5CC3 Q37274054-54D2C559-6237-4F64-92EA-5B31F2B24425 Q37371263-1B71FB7D-F1D1-4D36-B8D2-B4518AEBFBEE Q37436594-2858C55B-80F7-486A-A412-9566EFF9D0FA Q37484834-5932E1E2-E25F-46C4-B6C8-D4E4B8329549 Q37671955-637235A8-D742-4083-A957-433DA05ACB25 Q38114911-C2CB677F-D906-4C33-B829-B26821869CEA Q38139934-91CBB312-7F4A-4426-A030-56CE41D090DB Q40196920-8A1F54C9-B8FE-46F2-BF07-E545C3C23C8A Q40458446-73492B50-CECC-4E62-AB86-EE79B15602E9 Q41294691-DAC3FD35-074B-45E4-8FC5-11BCC68A16B2 Q44250284-B5AFFE06-5BAB-4A34-9F3F-FC94939388C9 Q51299240-7F70D93A-8D78-4F54-829D-49EC24ECC673 Q51352433-D0812082-1E4F-47B4-A6B0-EEF967BA3424 Q51859231-74430764-9A9D-46F1-8982-312E63F11545

P2860

Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals.

http://www.wikidata.org/entity/Q33991362

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Initiation of antiretroviral t ...... s in HIV-infected individuals.

@ast

Initiation of antiretroviral t ...... s in HIV-infected individuals.

@en

type

label

Initiation of antiretroviral t ...... s in HIV-infected individuals.

@ast

Initiation of antiretroviral t ...... s in HIV-infected individuals.

@en

prefLabel

Initiation of antiretroviral t ...... s in HIV-infected individuals.

@ast

Initiation of antiretroviral t ...... s in HIV-infected individuals.

@en

P1433

Q33991362-86512AAC-12EC-4D2F-9FA8-FF6FCAB290DB

P1476

Q33991362-68372F74-AEBE-4344-A2D6-6C8574DAD1EA

P2093

Q33991362-533D574C-3ED2-4E50-93E6-C03B5CBC0A83

Q33991362-661BAEA3-5258-4359-9C55-EC1D6D6D97BA

Q33991362-6FBA52AB-3B77-4C24-9332-5AA7CE12335C

Q33991362-86B502FA-8382-4EC6-8FD6-4990CA92F9BA

Q33991362-F2152C55-3439-4B8A-A198-B04C496EBFE1

P2860

Q33991362-00F12023-2C8E-4EF0-B851-5C6CFC1BA2D1

Q33991362-04550852-202C-4F81-9BD1-4179FF024F4A

Q33991362-09EF9BD6-F019-4FE2-BB25-203BA6B027EF

Q33991362-0B75D4F0-A892-40F5-B695-E1F5075DE836

Q33991362-1AA1AC1A-C301-4C07-91B2-AE15F3986250

Q33991362-1EB5DF80-78EA-48E0-9D6A-DF7A1C6D8416

Q33991362-239A00B0-A826-419D-B5F6-9BDD7255F2EA

Q33991362-293D2DF6-0959-4EC3-837E-25BCD060CCB2

Q33991362-33B696AE-8BCF-4C4E-9BD5-4BADC2014FB5

Q33991362-40C2BA1A-DD8F-43CF-8541-5603E7C08CCA

P304

Q33991362-906EF041-464B-4F5F-9A9B-98087E85C64D

P31

Q33991362-656A4650-0999-4868-A480-1BB048141EA6

P356

Q33991362-B8A03150-1F3D-4461-A2A4-1FDDA71409CC

P407

Q33991362-A6B3D8A7-DFBF-4A74-AEBA-B9AA3CA4C20D

P433

Q33991362-05836556-FA9D-4CE2-AA91-36753D67BB91

P478

Q33991362-FB8E6535-FBC0-4744-94A0-E88DC79D352C

P50

Q33991362-2E98BB39-3940-469B-85F6-8EE3661D321C

Q33991362-82E834EA-CA6C-4ACE-88AD-DEF4F29A6A50

Q33991362-DC4733BA-3AE5-453F-AD72-801758962DF8

P577

Q33991362-3EB24DAE-8814-4C27-B013-91FF910DE9DA

P698

Q33991362-7DC7A04E-05A2-4CBD-AD47-ECCEC23803F4

P921

Q33991362-DC3FAF5B-F07D-464D-A035-351BE72EDAFE

P932

Q33991362-A0F8896E-29B6-4278-9364-1C6116D2A0D3

P356

QAD.0B013E32833BEE44

P1433

P1476

Initiation of antiretroviral t ...... s in HIV-infected individuals.

@en

P2093

Amanda Schnell

http://www.w3.org/2001/XMLSchema#string

Jeffrey N Martin

http://www.w3.org/2001/XMLSchema#string

Peter Ganz

http://www.w3.org/2001/XMLSchema#string

Priscilla Y Hsue

http://www.w3.org/2001/XMLSchema#string

Yu Xie

http://www.w3.org/2001/XMLSchema#string

P2860

Microbial translocation is a cause of systemic immune activation in chronic HIV infection

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

Prediction of creatinine clearance from serum creatinine

CD4+ count-guided interruption of antiretroviral treatment

Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients.

Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

Clinical applications of arterial stiffness: therapeutics and pharmacology.

Augmentation index as a measure of peripheral vascular disease state.

Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study.

P304

1897-1905

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E32833BEE44

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Frederick M. Hecht

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20543654

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2903431

http://www.w3.org/2001/XMLSchema#string